Neuphoria Therapeutics Inc.
NEUP
주식 순위
#29127
Neuphoria Therapeutics, Inc. is a biotechnology company currently advancing... Neuphoria Therapeutics, Inc. is a biotechnology company currently advancing treatments through clinical trials. Its core mission involves pioneering therapies specifically engineered to address the intricate requirements of individuals living with neuropsychiatric disorders. The company was established on December 23, 2024, and its main corporate offices are located in Burlington, Massachusetts.
주가
$3.92
마지막 동기화: 2026-07-31
시가총액
$21.16M
변동 (1일)
-0.13%
변동 (1년)
60,767.52%
국가
US
거래 Neuphoria Therapeutics Inc. (NEUP)
카테고리
Healthcare
Neuphoria Therapeutics Inc. (NEUP)의 주가 이력
최고 종가: $0.01 (2023-08-01 기준)
최저 종가: $0.56 (1999-12-01 기준)
최저 종가: $0.56 (1999-12-01 기준)
Neuphoria Therapeutics Inc.의 주가 이력 (1999 ~ 2026)
연간 주가 성과
| 연도 | 성과 |
|---|---|
| 2023 | -78.35% |
| 2022 | -97.66% |
| 2021 | 1,363.12% |
| 2020 | 63.69% |
| 2019 | -30.83% |
| 2018 | -71.66% |
| 2017 | 18.70% |
| 2016 | -12.16% |
| 2015 | -19.29% |
| 2014 | -47.97% |
| 2013 | 95.06% |
| 2012 | -36.40% |
| 2011 | -90.46% |
| 2010 | 1,655.11% |
| 2009 | 133.43% |
| 2008 | -61.74% |
| 2007 | 121.34% |
| 2006 | 1.97% |
| 2005 | -16.73% |
| 2004 | -11.05% |
| 2003 | -22.47% |
| 2002 | -28.01% |
| 2001 | -20.19% |
| 2000 | -11.88% |
| 1999 | 0.00% |
유사 기업 또는 경쟁사의 주가
| 회사 | 주가 | 변동률 1년% | 국가 |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $752.87 | 7.01% |
CH
|
